A vaccine to prevent mosquito-spread Malaria is to be introduced. It is believed that the vaccine will hit markets by 2015. The vaccine was developed by British drug company GlaxoSmithKline. The vaccine showed a significant decrease in the impact of the disease in children in Africa where tests were done.
The vaccine known as RTS, S was able to prevent the disease in at least 50% of children as well as 25% of new born babies.
GlaxoSmithKline has submitted these findings to the European Medicines Agency seeking regulatory approval for sale of its vaccine in 2015. Following this the World Health Organisation has promised their support.
Thousands of people die of malaria all over the world. Most of them being new borns in Africa.